Dual ablation of FABP4 and FABP5 was shown to protect from metabolic disorders including insulin resistance, fatty liver, and atherosclerosis more than does a single deficiency of FABP4 or that of FABP5 in mouse models (4, 5, 44–46). The gene discussed is FABP5; the disease is digestive system neoplasm.